$GERN
GERON CORP Stock $gern

$gern Overview Financials Valuation SEC Filings Company Website

2014 Q3 Form 10-Q Financial Statement

#000110465914059373 Filed on August 11, 2014

Income Statement

Concept	2014 Q3	2014 Q2	2013 Q4
Revenue	$160.0K	$340.0K	$225.0K
YoY Change	-11.6%	203.57%	-67.34%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$4.070M	$3.850M	$3.980M
YoY Change	17.63%	12.24%	-14.78%
% of Gross Profit
Research & Development	$5.990M	$5.151M	$5.090M
YoY Change	12.21%	7.16%	-56.86%
% of Gross Profit
Depreciation & Amortization	$10.00K	$10.00K	-$40.00K
YoY Change	-90.0%	-91.67%	-123.53%
% of Gross Profit
Operating Expenses	$10.07M	$5.151M	$9.500M
YoY Change	12.97%	-43.25%	-50.45%
Operating Profit
YoY Change
Interest Expense	$360.0K	-$70.00K	-$10.00K
YoY Change	-25.0%	-450.0%	-100.38%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$9.550M	-$8.730M	-$9.280M
YoY Change	15.76%	-2.46%	-41.49%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$9.550M	-$8.730M	-$9.281M
YoY Change	15.7%	-2.43%	-41.49%
Net Earnings / Revenue	-5968.75%	-2567.65%	-4124.89%
Basic Earnings Per Share
Diluted Earnings Per Share	-$60.89K	-$55.71K	-$71.89K
COMMON SHARES
Basic Shares Outstanding	156.9M shares	156.9M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2014 Q3	2014 Q2	2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$126.4M	$140.3M	$65.20M
YoY Change	90.94%	98.16%	-31.73%
Cash & Equivalents	$7.600M	$9.520M	$12.99M
Short-Term Investments	$118.8M	$130.8M	$52.20M
Other Short-Term Assets	$1.000M	$1.000M	$1.300M
YoY Change	-37.5%	-16.67%	-38.1%
Inventory
Prepaid Expenses		$205.0K	$474.0K
Receivables
Other Receivables
Total Short-Term Assets	$128.2M	$142.6M	$67.06M
YoY Change	87.42%	96.87%	-31.86%
LONG-TERM ASSETS
Property, Plant & Equipment	$100.0K	$60.00K	$92.00K
YoY Change	-13.79%	-89.4%	-90.55%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$15.80M	$6.500M
YoY Change
Other Assets	$200.0K	$200.0K	$200.0K
YoY Change	0.0%	-50.0%	-50.0%
Total Long-Term Assets	$16.00M	$6.747M	$287.0K
YoY Change	5044.69%	588.47%	-79.26%
TOTAL ASSETS
Total Short-Term Assets	$128.2M	$142.6M	$67.06M
Total Long-Term Assets	$16.00M	$6.747M	$287.0K
Total Assets	$144.2M	$149.3M	$67.34M
YoY Change	109.86%	103.43%	-32.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.400M	$1.223M	$1.397M
YoY Change	55.14%	4.0%	-59.26%
Accrued Expenses	$4.700M	$1.057M	$1.783M
YoY Change	136.78%	-22.16%	-48.76%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$7.100M	$4.756M	$7.587M
YoY Change	3.85%	-4.96%	-46.37%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.100M	$4.756M	$7.587M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$7.100M	$4.800M	$7.600M
YoY Change	4.41%	-4.0%	-46.1%
SHAREHOLDERS EQUITY
Retained Earnings		-$909.9M	-$892.8M
YoY Change		3.97%	4.49%
Common Stock		$1.055B	$952.5M
YoY Change		11.75%	1.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$137.2M	$144.6M	$59.76M
YoY Change
Total Liabilities & Shareholders Equity	$144.2M	$149.3M	$67.34M
YoY Change	109.86%	103.43%	-32.52%

Cashflow Statement

Concept	2014 Q3	2014 Q2	2013 Q4
OPERATING ACTIVITIES
Net Income	-$9.550M	-$8.730M	-$9.281M
YoY Change	15.7%	-2.43%	-41.49%
Depreciation, Depletion And Amortization	$10.00K	$10.00K	-$40.00K
YoY Change	-90.0%	-91.67%	-123.53%
Cash From Operating Activities	-$4.470M	-$5.150M	-$6.800M
YoY Change	-21.99%	-34.97%	-34.74%
INVESTING ACTIVITIES
Capital Expenditures	-$10.00K	$0.00	$60.00K
YoY Change		-100.0%	-700.0%
Acquisitions
YoY Change
Other Investing Activities	$2.460M	$3.240M	$4.090M
YoY Change	-59.34%	163.41%	-75.08%
Cash From Investing Activities	$2.450M	$3.240M	$4.140M
YoY Change	-59.44%	167.77%	-74.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	100.0K	110.0K	6.060M
YoY Change	-76.74%	120.0%	8557.14%
NET CHANGE
Cash From Operating Activities	-4.470M	-5.150M	-6.800M
Cash From Investing Activities	2.450M	3.240M	4.140M
Cash From Financing Activities	100.0K	110.0K	6.060M
Net Change In Cash	-1.920M	-1.800M	3.400M
YoY Change	-359.46%	-72.97%	-43.8%
FREE CASH FLOW
Cash From Operating Activities	-$4.470M	-$5.150M	-$6.800M
Capital Expenditures	-$10.00K	$0.00	$60.00K
Free Cash Flow	-$4.460M	-$5.150M	-$6.860M
YoY Change	-22.16%	-34.73%	-34.1%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3743000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3723521	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6533	shares
CY2014Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	786999	shares
CY2013Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8310	shares
	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P4Y
CY2014Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2102000	USD
CY2013Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	886000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2234000	USD
CY2014Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	7307000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	7307000	USD
CY2014Q2	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	137332000	USD
CY2014Q2	gern	Gross Unrealized Gains Available For Sale Securities GrossUnrealizedGainsAvailableForSaleSecurities	17000	USD
CY2014Q2	gern	Gross Unrealized Losses Available For Sale Securities GrossUnrealizedLossesAvailableForSaleSecurities	37000	USD
CY2014Q2	us-gaap	Available For Sale Securities AvailableForSaleSecurities	137312000	USD
CY2013Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	10285000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	10285000	USD
CY2013Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	52248000	USD
CY2013Q4	gern	Gross Unrealized Gains Available For Sale Securities GrossUnrealizedGainsAvailableForSaleSecurities	5000	USD
CY2013Q4	gern	Gross Unrealized Losses Available For Sale Securities GrossUnrealizedLossesAvailableForSaleSecurities	19000	USD
CY2013Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	52234000	USD
CY2014Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	92645000	USD
CY2013Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	41007000	USD
CY2013	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Term1 ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1	P1Y
	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Term1 ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1	P9M
CY2013Q4	gern	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Aggregate Losses AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAggregateLosses	19000	USD
CY2014Q2	gern	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Aggregate Losses AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsAggregateLosses	37000	USD
CY2013Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	41007000	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	952403000	USD
CY2014Q2	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue	92645000	USD
CY2013Q4	gern	Available For Sale Securities Continuous Unrealized Loss Position Aggregate Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAggregateLoss	19000	USD
CY2014Q2	gern	Available For Sale Securities Continuous Unrealized Loss Position Aggregate Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAggregateLoss	37000	USD
CY2013	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Dividend Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate	0.00	pure
CY2013	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Volatility Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate	0.844	pure
CY2013	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Risk Free Interest Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate	0.0013	pure
	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Risk Free Interest Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate	0.0011	pure
	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Volatility Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate	1.520	pure
	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Dividend Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate	0.00	pure
CY2013Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	94000	USD
CY2014Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	25875000	shares
	us-gaap	Payments For Restructuring PaymentsForRestructuring	92000	USD
	us-gaap	Restructuring Reserve Accrual Adjustment RestructuringReserveAccrualAdjustment	-2000	USD
CY2014Q1	gern	Equity Issuance Per Share Amount At Public Offering EquityIssuancePerShareAmountAtPublicOffering	4.00
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	item
	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	313000	USD
	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	839000	USD
CY2014Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9520000	USD
	us-gaap	Available For Sale Securities Change In Net Unrealized Holding Gain Loss AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss	-6000	USD
	us-gaap	Available For Sale Securities Change In Net Unrealized Holding Gain Loss AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss	-53000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	59757000	USD
	us-gaap	Operating Expenses OperatingExpenses	21827000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Use of Estimates</font></b></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 13.5pt; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. On a regular basis, management evaluates these estimates and assumptions. Actual results could differ from those estimates.</font></p> </div>
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12990000	USD
CY2014Q2	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	795000	USD
CY2013Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	795000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22063000	USD
CY2013Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	52234000	USD
CY2013Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8834000	USD
CY2013Q4	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	564000	USD
CY2013Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	474000	USD
CY2014Q2	us-gaap	Assets Current AssetsCurrent	142592000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	67057000	USD
CY2014Q2	us-gaap	Available For Sale Securities Noncurrent AvailableForSaleSecuritiesNoncurrent	6496000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	92000	USD
CY2013Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	195000	USD
CY2014Q2	us-gaap	Assets Assets	149339000	USD
CY2013Q4	us-gaap	Assets Assets	67344000	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1397000	USD
CY2013Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3946000	USD
CY2013Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1783000	USD
CY2014Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	290000	USD
CY2013Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	367000	USD
CY2014Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4756000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	7587000	USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	131000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	67344000	USD
	us-gaap	Operating Expenses OperatingExpenses	18209000	USD
CY2013Q2	gern	Licenses And Royalty Revenue LicensesAndRoyaltyRevenue	112000	USD
CY2014Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	149339000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-892763000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-14000	USD
CY2014Q2	us-gaap	Stockholders Equity StockholdersEquity	144583000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	10865000	USD
	gern	Licenses And Royalty Revenue LicensesAndRoyaltyRevenue	877000	USD
CY2013Q2	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	4807000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8183000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	60000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	12728000	USD
CY2013Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3432000	USD
CY2013Q2	us-gaap	Operating Expenses OperatingExpenses	9077000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	97725000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-86540000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-17394000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-20950000	USD
CY2013Q2	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-24000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	77000	USD
CY2013Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	56000	USD
	us-gaap	Interest And Other Income InterestAndOtherIncome	137000	USD
CY2013Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	14000	USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	32000	USD
CY2013Q2	us-gaap	Net Income Loss NetIncomeLoss	-8947000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-17174000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-20844000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7847000	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.16
CY2013Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	128162993	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	128072962	shares
CY2013Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-31000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-53000	USD
CY2013Q2	us-gaap	Restructuring Charges RestructuringCharges	838000	USD
	us-gaap	Restructuring Charges RestructuringCharges	916000	USD
CY2014Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8664000	USD
CY2013Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8978000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17180000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20897000	USD
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	264000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-647000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	116000	USD
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	200000	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	53000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	2234000	USD
	gern	Amortization Related To Share Based Matching Contributions AmortizationRelatedToShareBasedMatchingContributions	465000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1248000	USD
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-8304000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-14655000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-24154000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	1000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	56000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	116000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	40110000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	50916000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-3470000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-13229000	USD
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-2441000	USD
	dei	Entity Registrant Name EntityRegistrantName	GERON CORP
	dei	Entity Central Index Key EntityCentralIndexKey	0000886744
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2014-06-30
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2014Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	156883508	shares
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2014Q2	us-gaap	Common Stock Value CommonStockValue	157000	USD
CY2014Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	96805000	USD
CY2014Q2	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	130816000	USD
CY2014Q2	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	1256000	USD
CY2014Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	205000	USD
CY2014Q2	gern	Licenses And Royalty Revenue LicensesAndRoyaltyRevenue	341000	USD
CY2014Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	60000	USD
CY2014Q2	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	191000	USD
CY2014Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1223000	USD
CY2014Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2186000	USD
CY2014Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1057000	USD
CY2014Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1054383000	USD
CY2014Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-909937000	USD
CY2014Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-20000	USD
	gern	Licenses And Royalty Revenue LicensesAndRoyaltyRevenue	815000	USD
CY2014Q2	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	5151000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	10362000	USD
CY2014Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3853000	USD
CY2014Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	70000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-6000	USD
CY2014Q2	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-147000	USD
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	1000	USD
CY2014Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	99000	USD
	us-gaap	Interest And Other Income InterestAndOtherIncome	182000	USD
CY2014Q2	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	23000	USD
	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	39000	USD
CY2014Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.06
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.11
CY2014Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	156706196	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	150086007	shares
	us-gaap	Depreciation Nonproduction DepreciationNonproduction	29000	USD
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-1456000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-3000	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	149000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3743000	USD
	gern	Amortization Related To Share Based Matching Contributions AmortizationRelatedToShareBasedMatchingContributions	76000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	419000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	128203000	USD
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	41663000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	97725000	USD
CY2014Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	156924100	shares
CY2014Q2	us-gaap	Restricted Investments At Fair Value RestrictedInvestmentsAtFairValue	795000	USD
CY2013Q4	us-gaap	Restricted Investments At Fair Value RestrictedInvestmentsAtFairValue	795000	USD

Files In Submission

Name	View Source	Status
0001104659-14-059373-index-headers.html	Edgar Link	pending
0001104659-14-059373-index.html	Edgar Link	pending
0001104659-14-059373.txt	Edgar Link	pending
0001104659-14-059373-xbrl.zip	Edgar Link	pending
a14-13977_110q.htm	Edgar Link	pending
a14-13977_1ex31d1.htm	Edgar Link	pending
a14-13977_1ex31d2.htm	Edgar Link	pending
a14-13977_1ex32d1.htm	Edgar Link	pending
a14-13977_1ex32d2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gern-20140630.xml	Edgar Link	completed
gern-20140630.xsd	Edgar Link	pending
gern-20140630_cal.xml	Edgar Link	unprocessable
gern-20140630_def.xml	Edgar Link	unprocessable
gern-20140630_lab.xml	Edgar Link	unprocessable
gern-20140630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GERN
GERON CORP Stock $gern

2014 Q3 Form 10-Q Financial Statement

#000110465914059373 Filed on August 11, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GERN GERON CORP Stock $gern

2014 Q3 Form 10-Q Financial Statement

#000110465914059373 Filed on August 11, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GERN
GERON CORP Stock $gern